About Index Trending news
Analyze
Top 50 Pricing
Benevir Biopharm

Benevir Biopharm

Work at Benevir Biopharm? Add yourself to this profile

Benevir Biopharm

In the emerging field of oncolytic virotherapy, BeneVir is developing an improved therapeutic platform that can be adapted to target a wide variety of cancers.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series Undisclosed)
$3,000,000
Venture capital
$2,000,000
Employees

Unknown size

Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Benevir Biopharm makes some noise.